Immunohistochemical analysis of pro- and active-caspase 3 in larygeal squamous cell carcinoma

Virchows Archiv

Volumn 444, Issue 5, 2004, Pages 439-446

  Cör, Andrej ^a   Pižem, Jože ^b   Gale, Nina ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b INSTITUTE OF PATHOLOGY   (Slovenia)

Author keywords

Apoptosis; Caspase; Laryngeal squamous cell carcinoma; p53

Indexed keywords

CASPASE 3; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LARYNX TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; SURVIVAL;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CASPASE 3; CASPASES; CELL COUNT; ENZYME PRECURSORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 2642571717     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-0997-1     Document Type: Article

References (37)

1. Cohen GM (1997) Caspases: the executioners of apoptosis. Biochem J 326:1-6
2. Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS (1999) Bax-dependent caspase 3 activation is a key determinant in p53-induced apoptosis in neurons. J Neuroscience 15:7860-7869
3. Deverajan E, Sahin AA, Chen JS, Kristnamurthy RR, Aggarwal N, Sapino AM, Zhang F, Sharma D, Yang XH, Tira AD, Mehta K (2002) Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistence. Oncogene 21:8843-8851
4. Donoghue S, Baden HS, Lauder I, Sobolewski S, Pringle HJ (1999) Immunohistochemical localization of caspase 3 correlates with clinical outcome in B cell diffuse large-cell lymphoma. Cancer Res 59:5386-5391
5. Duan WR, Garner DS, Williams SD, Funckes-Shippy L, Spath IS (2003) Comparison of immunohistochemistry for activated caspase 3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199:221-228
6. Dukers DF, Meijer CJL, Berge L, Vos W, Ossenkoppele GJ, Oudejans JJ (2002) High numbers of active-caspase 3-positive Reed-Sternberg cells in pre-treatment biopsy specimens of patients with Hodgkin disease predict favourable clinical outcome. Blood 100:36-42
7. Fujikawa K, Shiraki K Sugimoto K, Ito T, Yamanaka T, Takase K, Nakano T (2000) Reduced expression of ICE/caspase 1 and CPP32/caspase3 in human hepatocellular carcinoma. Anticancer Res 20:1927-1932
8. Gown AM, Willingham MC (2002) Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. J Histochem Cytochem 50:449-454
9. Hadjiloucas I, Gilmore AP, Bundred NJ, Streuli CH (2001) Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics. Br J Cancer 85:1522-1526
10. Hirvikoski P, Virtaniemi J, Kumpulainen E, Johansson R, Kosma VM (2002) Supraglottic and glottic carcinomas: clinically and biologically distinct entities? Eur J Cancer 38:1717-1723
11. Hoshi T, Sasano H, Koto K, Yabuki, Ohara S, Konno R, Asaki S, Toyota T, Tateno H, Nagura H (1998) Immunohistochemistry of caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 18:4347-4354
12. Hsia JY, Chen CY, Chen JT, Hsu CP, Shai SE, Yang SS, Chuang CY, Wang PY, Miaw J (2003) Prognostic significance of caspase 3 expression in primary resected esophageal squamous carcinoma. EJSO 29:44-48
13. Izawa H, Yonemitsu N, Shin T, Sugihara H (1999) Histopathological analysis of apoptosis, and expression of p53, bcl-2, bax, and Ki-67 in laryngeal squamous cell carcinomas and dysplasia. Auris Nasus Larynx 26:317-330
14. Kambič V (1997) Epithelial hyperplastic lesions - a challenging topic in laryngology. Acta Otolaryngol 527[Suppl]:7-11
15. Kase S, Osaki M, Honjo S, Adachi H, Tsujitani S, Kaibara N, Ito H (2003) Expression of cyclo-oxygenase-2 is correlated with high intratumoral microvessel density and low apoptotic index in human esophageal squamous cell carcinomas Virchows Arch 442:129-135
16. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26:239-257
17. Koizumi H, Ohkawa I, Tsukahara T, Momoi T, Nakada K, Uchikoshi T (1999) Apoptosis in favourable neuroblastomas is not dependent on Fas (CD95/APO1) expression but on activated caspase 3 (CPP32). J Pathol 189:410-415
18. Koomagi R, Volm M (2000) Relationship between the expression of caspase 3 and the clinical outcome of patients with non-small cell lung cancer. Anticancer Res 20:393-496
19. Krajewska M, Wong H, Krajevski S, Zapata JM, Shabaik A, Goscoyne R, Reed JC (1997) Immunohistochemical analysis of in vivo patterns of expression of CPP32 (caspase 3), a cell death protease. Cancer Res 57:1605-1613
20. Miyashita T, Reed JC (1995) Tumour suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 80:293-299
21. Nakagawara A, Nakamura Y, Ikead H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A, Sakiyama S (1997) High levels of expression and nuclear localization of inteleukih-1 β converting enzyme (ICE) and CPP32 in favourable human neuroblastomas. Cancer Res 57:4578-4584
22. Nicholson DW (2000) From bench to clinic with apoptosis-based therapeutic agents. Nature 407:810-816
23. Pižem J, Cör A, Gale N (2004) Survivin is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology (in press)
24. Ramuz O, Isnardon D, Devilard E, Chorafe-Jauffret E, Hasson-Xeri L (2003) Constitutive nuclear localization and initial cytoplasmic activation of endogeneous caspase 3 evidenced by confocal microscopy. Int Exp Pathol 84:75-81
25. Sarasin A, Stary A (1997) Human cancer and DNA repair-deficient disease. Cancer Detect Prev 21:406-411
26. Sasaki CT, Jassin B (2001) Cancer of the pharynx and larynx. Am J Med 111:118S-123S
27. Shanmugaratnam K (1991) WHO: histological typing of tumours of the upper respiratory tract and ear, 2nd edn. Springer, Berlin Heidelberg New York
28. Sohn JH, Kim DH, Choi NG, Park YE, Ro JY (2000) Caspase 3/CPP32 immunoreactivity and its correlation with frequency of apoptotic bodies in human prostatic carcinomas and benign hyperplasias. Histopathology 37:555-560
29. Takata T, Tanaka F, Yamada T, Yanagihara K, Otake Y, Kawano Y, Nakagawa T, Miyahara R, Oyanagi H, Inui K, Wada H (2001) Clinical significance of caspase 3 expression in pathologic-stage I, nonsmall-cell lung cancer. Int J Cancer 96:54-60
30. Tan G, Hequing L, Jiangbo C (2002) Apoptosis induced by low-dose paclitaxel is associated with p53 upregulated in nasopharyngeal carcinoma cells. Int J Cancer 97:168-172
31. Törmännen-Näpänkangas U, Soini Y, Kahlos K, Kinnula V, Pääkkö P (2001) Expression of caspase 3, -6 and -8 and their relation to apoptosis in non-small cell lung carcinoma. Int J Cancer 93:192-198
32. Trask DG, Wolf GT, Bradford CR, Fisher SG, Deveney K, Johnson M, Singleton T (2002) Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation. Laryngoscope 112:638-644
33. Vakkala M, Pääkkö P, Soini Y (1999) Expression of caspase 3, 6, and 8 is increased in parallel with the apoptosis and histological aggressiveness of the breast lesion. Br J Cancer 81:592-599
34. Volm M, Mattern J, Koomagi R (1999) Inverse correlation between apoptotic (Fas ligand, caspase 3) and angiogenic factors (VGEF, microvessel density) in squamous cell lung carcinoma. Anticancer Res 19:1669-1671
35. Wagata T, Shibagaki I, Immamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K (1993) Loss of 17p mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. Cancer Res 53:846-850
36. Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A (2002) Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int J Cancer 99:22-28
37. Winter RN, Kramer A, Borkowski A, Kyprianou N (2001) Loss of caspase 1 and caspase 3 protein expression in human prostate cancer. Cancer Res 61:1227-1232